Results for tag: "Vaso Occlusive Crisis Drug"

The Vaso Occlusive Crisis Drug market is a subset of the Cardiovascular Drugs market. It is composed of drugs used to treat vaso-occlusive crises, a type of pain crisis that occurs in patients with sickle cell disease. These drugs are used to reduce the severity and duration of pain crises, as well as to reduce the risk of organ damage. Commonly used drugs in this market include hydroxyurea, anagrelide, and crizanlizumab. The Vaso Occlusive Crisis Drug market is highly competitive, with many companies offering products. Some of the major players in this market include Novartis, GlaxoSmithKline, Pfizer, Sanofi, and Bristol-Myers Squibb. Show Less Read more